Enovix (ENVX) Financials

$8.07 -0.23 (-2.77%)

Closing price 04:00 PM Eastern

Extended Trading

$8.11 +0.04 (+0.45%)

As of 07:22 PM Eastern

Annual Income Statements for Enovix

This table shows Enovix's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020
Period end date	12/29/2024	12/31/2023	1/1/2023	1/2/2022	12/31/2020
Net Income / (Loss) Attributable to Common Shareholders	-222	-214	-52	-126	-40
Consolidated Net Income / (Loss)	-223	-214	-52	-126	-40
Net Income / (Loss) Continuing Operations	-223	-214	-52	-126	-40
Total Pre-Tax Income	-224	-215	-52	-126	-40
Total Operating Income	-243	-230	-132	-70	-24
Total Gross Profit	-2.05	-55	-17	-1.97	-3.38
Total Revenue	23	7.64	6.20	0.00	0.00
Operating Revenue	23	7.64	6.20	0.00	0.00
Total Cost of Revenue	25	63	23	1.97	3.38
Operating Cost of Revenue	25	63	23	1.97	3.38
Total Operating Expenses	241	175	115	68	20
Selling, General & Admin Expense	74	79	52	30	5.71
Research & Development Expense	125	88	58	38	14
Impairment Charge	0.00	4.41	4.92	0.00	0.00
Restructuring Charge	42	3.02	0.00	0.00	-
Total Other Income / (Expense), net	19	15	80	-56	-16
Interest Expense	6.79	4.46	-	0.19	0.11
Interest & Investment Income	12	14	5.23	0.04	-
Other Income / (Expense), net	13	5.88	75	-56	-16
Income Tax Expense	-1.39	-0.63	0.00	0.00	-
Net Income / (Loss) Attributable to Noncontrolling Interest	-0.29	-0.06	0.00	0.00	-
Basic Earnings per Share	($1.27)	($1.35)	($0.34)	($1.07)	($0.49)
Weighted Average Basic Shares Outstanding	175.04M	159.07M	152.92M	117.22M	80.37M
Diluted Earnings per Share	($1.27)	($1.38)	($0.82)	($1.07)	($0.49)
Weighted Average Diluted Shares Outstanding	175.04M	159.58M	154.15M	117.22M	80.37M
Weighted Average Basic & Diluted Shares Outstanding	191.27M	168.50M	157.78M	117.22M	80.37M

This table shows Enovix's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/30/2025	12/29/2024	9/29/2024	6/30/2024	3/31/2024	12/31/2023	10/1/2023	7/2/2023	4/2/2023	1/1/2023	10/2/2022
Net Income / (Loss) Attributable to Common Shareholders	-24	-37	-23	-116	-46	-60	-16	-64	-74	-11	-82
Consolidated Net Income / (Loss)	-24	-37	-23	-116	-46	-60	-16	-64	-74	-11	-82
Net Income / (Loss) Continuing Operations	-24	-37	-23	-116	-46	-60	-16	-64	-74	-11	-82
Total Pre-Tax Income	-24	-36	-20	-121	-47	-61	-16	-64	-74	-11	-82
Total Operating Income	-43	-35	-49	-89	-70	-65	-50	-52	-63	-45	-34
Total Gross Profit	0.26	1.05	-0.64	-0.66	-1.80	-12	-17	-14	-12	-9.26	-6.62
Total Revenue	5.10	9.72	4.32	3.77	5.27	7.38	0.20	0.04	0.02	1.09	0.01
Operating Revenue	5.10	9.72	4.32	3.77	5.27	7.38	0.20	0.04	0.02	1.09	0.01
Total Cost of Revenue	4.84	8.67	4.96	4.42	7.07	20	17	14	12	10	6.63
Operating Cost of Revenue	4.84	8.67	4.96	4.42	7.07	20	17	14	12	10	6.63
Total Operating Expenses	43	36	49	88	68	52	34	38	51	36	27
Selling, General & Admin Expense	17	13	21	21	20	18	17	17	27	15	13
Research & Development Expense	26	22	24	29	49	35	14	17	24	16	14
Total Other Income / (Expense), net	19	-1.78	29	-32	23	4.11	34	-12	-10	34	-48
Interest Expense	1.72	1.72	1.72	1.69	1.66	1.63	1.56	1.27	0.00	-	0.00
Interest & Investment Income	2.43	2.59	2.86	3.33	3.56	4.13	4.33	3.15	2.47	-	1.75
Other Income / (Expense), net	18	-2.65	28	-33	22	1.61	31	-14	-13	31	-50
Income Tax Expense	-0.16	1.15	2.19	-4.59	-0.15	-0.63	0.00	0.00	0.00	-	-
Net Income / (Loss) Attributable to Noncontrolling Interest	-0.02	0.01	-0.10	-0.08	-0.13	-0.06	0.00	0.00	0.00	-	-
Basic Earnings per Share	($0.12)	($0.19)	($0.13)	($0.67)	($0.28)	($0.37)	($0.10)	($0.41)	($0.47)	($0.08)	($0.53)
Weighted Average Basic Shares Outstanding	191.30M	175.04M	176.68M	172.40M	168.14M	159.07M	159.83M	157.15M	155.63M	152.92M	153.33M
Diluted Earnings per Share	($0.12)	($0.02)	($0.30)	($0.67)	($0.28)	($0.21)	($0.29)	($0.41)	($0.47)	$0.05	($0.53)
Weighted Average Diluted Shares Outstanding	191.30M	175.04M	176.87M	172.40M	168.14M	159.58M	161.37M	157.15M	155.63M	154.15M	153.33M
Weighted Average Basic & Diluted Shares Outstanding	192.00M	191.27M	177.98M	176.28M	170.00M	168.50M	167.77M	320.25M	316.32M	157.78M	157.10M

This table details how cash moves in and out of Enovix's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020
Period end date	12/29/2024	12/31/2023	1/1/2023	1/2/2022	12/31/2020
Net Change in Cash & Equivalents	40	-88	-62	356	19
Net Cash From Operating Activities	-109	-105	-83	-51	-20
Net Cash From Continuing Operating Activities	-109	-105	-83	-51	-20
Net Income / (Loss) Continuing Operations	-223	-214	-52	-126	-40
Consolidated Net Income / (Loss)	-223	-214	-52	-126	-40
Depreciation Expense	45	34	7.97	1.52	0.58
Non-Cash Adjustments To Reconcile Net Income	85	68	-40	67	17
Changes in Operating Assets and Liabilities, net	-16	7.10	0.80	6.14	2.19
Net Cash From Investing Activities	-1.38	-143	-36	-44	-27
Net Cash From Continuing Investing Activities	-1.38	-143	-36	-44	-27
Purchase of Property, Plant & Equipment	-76	-62	-36	-44	-27
Acquisitions	0.00	-9.97	0.00	0.00	-
Purchase of Investments	-32	-138	0.00	0.00	-
Sale and/or Maturity of Investments	107	67	0.00	0.00	-
Net Cash From Financing Activities	151	160	57	451	66
Net Cash From Continuing Financing Activities	151	160	57	451	66
Repayment of Debt	-0.21	-5.99	0.00	-15	0.00
Repurchase of Common Equity	-0.00	-0.03	-0.01	-0.03	0.00
Issuance of Debt	4.57	173	0.00	15	1.63
Issuance of Common Equity	109	2.35	1.90	0.00	0.00
Other Financing Activities, net	38	-9.25	55	483	0.36
Effect of Exchange Rate Changes	-1.17	0.15	0.00	0.00	-
Cash Interest Paid	5.69	2.76	0.00	0.00	-
Cash Income Taxes Paid	0.19	0.00	0.00	-	-

This table details how cash moves in and out of Enovix's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/30/2025	12/29/2024	9/29/2024	6/30/2024	3/31/2024	12/31/2023	10/1/2023	7/2/2023	4/2/2023	1/1/2023	10/2/2022
Net Change in Cash & Equivalents	-83	72	-34	13	-11	-36	-72	49	-29	-26	-36
Net Cash From Operating Activities	-17	-16	-31	-27	-35	-27	-28	-24	-26	-22	-21
Net Cash From Continuing Operating Activities	-17	-16	-31	-27	-35	-27	-28	-24	-26	-22	-21
Net Income / (Loss) Continuing Operations	-24	-37	-23	-116	-46	-60	-16	-64	-74	-11	-82
Consolidated Net Income / (Loss)	-24	-37	-23	-116	-46	-60	-16	-64	-74	-11	-82
Depreciation Expense	8.45	7.54	6.50	5.94	25	24	2.90	3.50	3.60	3.58	2.86
Non-Cash Adjustments To Reconcile Net Income	-3.30	16	-9.92	88	-8.19	10	-18	34	42	-18	59
Changes in Operating Assets and Liabilities, net	1.48	-1.66	-4.62	-4.75	-5.33	-1.48	2.73	3.46	2.40	4.14	-0.45
Net Cash From Investing Activities	-64	-16	-4.53	0.41	19	-11	-51	-78	-3.03	-4.85	-17
Net Cash From Continuing Investing Activities	-64	-16	-4.53	0.41	19	-11	-51	-78	-3.03	-4.85	-17
Purchase of Property, Plant & Equipment	-6.27	-16	-20	-25	-15	-29	-17	-13	-3.03	-4.85	-17
Acquisitions	-0.02	-	-	-	-	-	-	-	-	-	-
Purchase of Investments	-58	-	-	-15	-17	-23	-50	-66	0.00	-	-
Sale and/or Maturity of Investments	0.00	-	15	40	51	50	17	-	0.00	-	-
Net Cash From Financing Activities	-1.49	107	-0.86	40	5.43	2.20	6.47	151	-0.46	0.53	1.77
Net Cash From Continuing Financing Activities	-1.49	107	-0.86	40	5.43	2.20	6.47	151	-0.46	0.53	1.77
Payment of Dividends	-0.51	-	-	-	-	-	-	-	-	-	-
Issuance of Debt	0.00	-	-	2.77	1.80	-	-	173	0.00	-	-
Other Financing Activities, net	-0.98	-0.99	-0.75	36	3.63	1.75	6.50	-17	-0.45	-0.26	1.78
Effect of Exchange Rate Changes	-0.23	-2.47	2.05	-0.21	-0.54	0.15	-	-	0.00	-	-
Cash Interest Paid	0.13	2.74	0.18	2.75	0.02	2.76	-	-	0.00	-	-
Cash Income Taxes Paid	0.04	0.02	0.02	0.06	0.09	-	-	-	0.00	-	-

This table presents Enovix's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020
Period end date	12/29/2024	12/31/2023	1/1/2023	1/2/2022	12/31/2020
Total Assets	527	564	441	483	65
Total Current Assets	295	323	330	398	33
Cash & Equivalents	273	233	323	385	29
Short-Term Investments	0.00	74	0.00	-	-
Note & Lease Receivable	0.00	1.51	0.00	-	-
Accounts Receivable	4.57	0.91	0.17	0.00	-
Inventories, net	7.66	8.74	0.63	0.00	-
Prepaid Expenses	9.90	5.20	5.99	8.27	0.95
Plant, Property, & Equipment, net	168	166	104	77	31
Total Noncurrent Assets	64	75	7.07	7.83	0.63
Goodwill	12	12	0.00	-	-
Intangible Assets	36	42	0.00	-	-
Other Noncurrent Operating Assets	16	20	7.07	7.83	0.63
Total Liabilities & Shareholders' Equity	527	564	441	483	65
Total Liabilities	278	303	84	156	29
Total Current Liabilities	54	61	23	21	11
Short-Term Debt	9.45	5.92	0.00	-	-
Accounts Payable	9.49	21	7.08	3.14	2.08
Accrued Expenses	20	14	7.09	7.11	2.00
Current Deferred Revenue	3.65	6.71	0.05	5.58	5.41
Current Employee Benefit Liabilities	8.23	11	8.10	4.10	1.27
Other Current Liabilities	3.04	2.44	0.72	0.71	0.11
Total Noncurrent Liabilities	224	242	61	136	18
Long-Term Debt	170	169	0.00	-	-
Noncurrent Deferred Revenue	3.77	3.77	3.72	2.29	1.65
Noncurrent Deferred & Payable Income Tax Liabilities	8.78	11	0.00	-	-
Other Noncurrent Operating Liabilities	42	59	57	134	16
Total Equity & Noncontrolling Interests	249	261	356	326	36
Total Preferred & Common Equity	247	258	356	326	36
Preferred Stock	0.00	0.00	0.00	0.00	0.00
Total Common Equity	247	258	356	326	36
Common Stock	1,068	857	741	659	243
Retained Earnings	-821	-599	-385	-333	-207
Accumulated Other Comprehensive Income / (Loss)	-0.14	-0.06	0.00	-	-
Other Equity Adjustments	0.00	-	0.00	-	-
Noncontrolling Interest	2.66	2.96	0.00	-	-

This table presents Enovix's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022
Period end date	3/30/2025	9/29/2024	6/30/2024	3/31/2024	10/1/2023	7/2/2023	4/2/2023	10/2/2022
Total Assets	499	448	489	509	520	539	411	468
Total Current Assets	270	224	270	278	376	414	301	356
Cash & Equivalents	190	201	235	222	271	343	294	349
Short-Term Investments	58	0.00	15	40	101	66	-	-
Note & Lease Receivable	1.26	0.00	0.00	0.14	-	-	-	-
Accounts Receivable	2.90	1.91	1.67	1.73	0.00	0.04	0.02	0.01
Inventories, net	10	9.56	9.51	6.54	0.22	0.80	0.82	0.45
Prepaid Expenses	7.38	12	8.84	7.21	4.18	2.93	5.86	4.51
Plant, Property, & Equipment, net	166	158	151	159	137	118	102	104
Total Noncurrent Assets	63	66	68	72	7.49	6.88	7.09	8.06
Goodwill	12	12	12	12	-	-	-	-
Intangible Assets	35	38	39	40	-	-	-	-
Other Noncurrent Operating Assets	16	17	17	20	7.49	6.88	7.09	8.06
Total Liabilities & Shareholders' Equity	499	448	489	509	520	539	411	468
Total Liabilities	261	278	316	277	267	292	98	109
Total Current Liabilities	58	59	68	57	44	37	25	18
Short-Term Debt	10	12	11	8.49	-	-	-	-
Accounts Payable	21	15	19	19	18	13	4.75	6.82
Accrued Expenses	8.54	14	17	12	16	13	8.69	2.48
Current Deferred Revenue	6.63	6.21	7.01	5.31	0.00	0.35	0.35	1.37
Current Employee Benefit Liabilities	6.48	8.04	8.86	9.28	9.13	10	10	6.17
Other Current Liabilities	5.16	4.76	5.09	2.86	0.94	0.94	0.92	0.70
Total Noncurrent Liabilities	203	218	248	220	223	254	73	92
Long-Term Debt	169	169	169	168	167	167	-	-
Noncurrent Deferred Revenue	0.30	3.77	3.77	3.77	3.77	3.42	3.42	2.96
Noncurrent Deferred & Payable Income Tax Liabilities	8.75	8.18	6.12	11	-	-	-	-
Other Noncurrent Operating Liabilities	25	38	70	37	52	84	70	89
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	238	170	173	232	252	247	312	358
Total Preferred & Common Equity	235	168	170	229	252	247	312	358
Total Common Equity	235	168	170	229	252	247	312	358
Common Stock	1,080	951	931	875	791	770	770	732
Retained Earnings	-845	-784	-761	-645	-539	-523	-458	-374
Accumulated Other Comprehensive Income / (Loss)	-0.18	-0.04	0.02	-0.05	-0.01	-0.02	-	-
Noncontrolling Interest	2.64	2.65	2.75	2.83	-	-	-	-

This table displays calculated financial ratios and metrics derived from Enovix's official financial filings.

Metric	2024	2023	2022	2021	2020
Period end date	12/29/2024	12/31/2023	1/1/2023	1/2/2022	12/31/2020
Growth Metrics	-	-	-	-	-
Revenue Growth	201.86%	23.25%	0.00%	0.00%	0.00%
EBITDA Growth	3.08%	-289.46%	60.65%	-218.78%	0.00%
EBIT Growth	-2.27%	-294.67%	54.78%	-217.94%	0.00%
NOPAT Growth	-5.39%	-74.46%	-89.84%	-195.46%	0.00%
Net Income Growth	-3.92%	-314.81%	58.99%	-217.46%	0.00%
EPS Growth	7.97%	-68.29%	23.36%	-118.37%	0.00%
Operating Cash Flow Growth	-3.82%	-26.46%	-61.27%	-155.89%	0.00%
Free Cash Flow Firm Growth	23.56%	-38.77%	-1,152.90%	0.00%	0.00%
Invested Capital Growth	20.50%	285.11%	156.74%	-936.65%	0.00%
Revenue Q/Q Growth	11.26%	463.72%	21.39%	0.00%	0.00%
EBITDA Q/Q Growth	4.91%	-17.78%	60.00%	0.00%	0.00%
EBIT Q/Q Growth	10.18%	-28.05%	55.39%	0.00%	0.00%
NOPAT Q/Q Growth	11.09%	-9.32%	-18.27%	0.00%	0.00%
Net Income Q/Q Growth	9.21%	-29.56%	58.71%	0.00%	0.00%
EPS Q/Q Growth	13.01%	-23.21%	44.59%	0.00%	0.00%
Operating Cash Flow Q/Q Growth	9.40%	-5.43%	-6.49%	-31.44%	0.00%
Free Cash Flow Firm Q/Q Growth	32.86%	-37.84%	0.00%	0.00%	0.00%
Invested Capital Q/Q Growth	4.13%	168.18%	261.97%	0.00%	0.00%
Profitability Metrics	-	-	-	-	-
Gross Margin	-8.86%	-724.97%	-274.70%	0.00%	0.00%
EBITDA Margin	-799.64%	-2,490.45%	-788.15%	0.00%	0.00%
Operating Margin	-1,051.70%	-3,012.23%	-2,128.01%	0.00%	0.00%
EBIT Margin	-994.50%	-2,935.36%	-916.69%	0.00%	0.00%
Profit (Net Income) Margin	-964.44%	-2,801.31%	-832.34%	0.00%	0.00%
Tax Burden Percent	99.38%	99.71%	100.00%	100.00%	100.00%
Interest Burden Percent	97.58%	95.72%	90.80%	100.12%	100.27%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	-119.16%	-197.91%	0.00%	0.00%	0.00%
ROIC Less NNEP Spread (ROIC-NNEP)	-72.43%	-174.62%	0.00%	0.00%	0.00%
Return on Net Nonoperating Assets (RNNOA)	31.98%	128.56%	0.00%	0.00%	0.00%
Return on Equity (ROE)	-87.18%	-69.35%	-15.13%	-69.48%	-109.48%
Cash Return on Invested Capital (CROIC)	-137.75%	-315.45%	-551.40%	0.00%	0.00%
Operating Return on Assets (OROA)	-42.05%	-44.66%	-12.32%	0.00%	0.00%
Return on Assets (ROA)	-40.78%	-42.62%	-11.18%	0.00%	0.00%
Return on Common Equity (ROCE)	-86.22%	-69.02%	-15.13%	-69.48%	-109.48%
Return on Equity Simple (ROE_SIMPLE)	-90.19%	-82.95%	-14.48%	-38.60%	-109.48%
Net Operating Profit after Tax (NOPAT)	-170	-161	-92	-49	-16
NOPAT Margin	-736.19%	-2,108.56%	-1,489.61%	0.00%	0.00%
Net Nonoperating Expense Percent (NNEP)	-46.73%	-23.29%	11.51%	-37.26%	-79.54%
Return On Investment Capital (ROIC_SIMPLE)	-39.63%	-36.96%	-25.92%	-	-
Cost of Revenue to Revenue	108.86%	824.97%	374.70%	0.00%	0.00%
SG&A Expenses to Revenue	322.06%	1,033.67%	837.96%	0.00%	0.00%
R&D to Revenue	539.59%	1,156.36%	936.00%	0.00%	0.00%
Operating Expenses to Revenue	1,042.84%	2,287.26%	1,853.31%	0.00%	0.00%
Earnings before Interest and Taxes (EBIT)	-229	-224	-57	-126	-40
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-185	-190	-49	-124	-39
Valuation Ratios	-	-	-	-	-
Price to Book Value (P/BV)	8.14	8.14	5.48	12.15	5.52
Price to Tangible Book Value (P/TBV)	10.13	10.30	5.48	12.15	5.52
Price to Revenue (P/Rev)	87.01	274.79	315.12	0.00	0.00
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	12.30	15.25	48.59	0.00	24.16
Enterprise Value to Revenue (EV/Rev)	83.07	257.94	263.06	0.00	0.00
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	203.43	0.00
Leverage & Solvency	-	-	-	-	-
Debt to Equity	0.72	0.67	0.00	0.00	0.00
Long-Term Debt to Equity	0.68	0.65	0.00	0.00	0.00
Financial Leverage	-0.44	-0.74	-1.04	-1.14	-0.80
Leverage Ratio	2.14	1.63	1.35	1.51	1.79
Compound Leverage Factor	2.09	1.56	1.23	1.51	1.80
Debt to Total Capital	41.82%	40.13%	0.00%	0.00%	0.00%
Short-Term Debt to Total Capital	2.20%	1.36%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	39.62%	38.77%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.62%	0.68%	0.00%	0.00%	0.00%
Common Equity to Total Capital	57.56%	59.19%	100.00%	100.00%	100.00%
Debt to EBITDA	-0.97	-0.92	0.00	0.00	0.00
Net Debt to EBITDA	0.51	0.69	0.00	0.00	0.00
Long-Term Debt to EBITDA	-0.92	-0.89	0.00	0.00	0.00
Debt to NOPAT	-1.06	-1.09	0.00	0.00	0.00
Net Debt to NOPAT	0.55	0.82	0.00	0.00	0.00
Long-Term Debt to NOPAT	-1.00	-1.05	0.00	0.00	0.00
Altman Z-Score	1.31	1.93	13.13	14.31	-1.89
Noncontrolling Interest Sharing Ratio	1.10%	0.48%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-
Current Ratio	5.49	5.30	14.31	19.29	3.04
Quick Ratio	5.17	5.07	14.03	18.67	2.68
Cash Flow Metrics	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-196	-257	-185	18	0.00
Operating Cash Flow to CapEx	-142.59%	-169.33%	-228.49%	-117.72%	-74.39%
Free Cash Flow to Firm to Interest Expense	-28.93	-57.65	0.00	94.03	0.00
Operating Cash Flow to Interest Expense	-16.01	-23.48	0.00	-274.36	-187.38
Operating Cash Flow Less CapEx to Interest Expense	-27.23	-37.35	0.00	-507.43	-439.28
Efficiency Ratios	-	-	-	-	-
Asset Turnover	0.04	0.02	0.01	0.00	0.00
Accounts Receivable Turnover	8.43	14.17	0.00	0.00	0.00
Inventory Turnover	3.06	13.46	0.00	0.00	0.00
Fixed Asset Turnover	0.14	0.06	0.07	0.00	0.00
Accounts Payable Turnover	1.63	4.45	4.55	0.75	1.62
Days Sales Outstanding (DSO)	43.30	25.76	0.00	0.00	0.00
Days Inventory Outstanding (DIO)	119.16	27.12	0.00	0.00	0.00
Days Payable Outstanding (DPO)	223.36	81.98	80.27	484.97	225.27
Cash Conversion Cycle (CCC)	-60.90	-29.10	-80.27	0.00	0.00
Capital & Investment Metrics	-	-	-	-	-
Invested Capital	156	129	34	-59	7.07
Invested Capital Turnover	0.16	0.09	-0.48	0.00	0.00
Increase / (Decrease) in Invested Capital	27	96	93	-66	0.00
Enterprise Value (EV)	1,917	1,972	1,632	3,577	171
Market Capitalization	2,008	2,101	1,954	3,962	200
Book Value per Share	$1.39	$1.54	$2.27	$2.25	$0.45
Tangible Book Value per Share	$1.11	$1.22	$2.27	$2.25	$0.45
Total Capital	429	436	356	326	36
Total Debt	179	175	0.00	0.00	0.00
Total Long-Term Debt	170	169	0.00	0.00	0.00
Net Debt	-94	-132	-323	-385	-29
Capital Expenditures (CapEx)	76	62	36	44	27
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-22	-39	-16	-7.81	-6.97
Debt-free Net Working Capital (DFNWC)	251	268	307	377	22
Net Working Capital (NWC)	241	262	307	377	22
Net Nonoperating Expense (NNE)	53	53	-41	77	23
Net Nonoperating Obligations (NNO)	-94	-132	-323	-385	-29
Total Depreciation and Amortization (D&A)	45	34	7.97	1.52	0.58
Debt-free, Cash-free Net Working Capital to Revenue	-95.83%	-506.79%	-261.72%	0.00%	0.00%
Debt-free Net Working Capital to Revenue	1,086.75%	3,507.01%	4,943.87%	0.00%	0.00%
Net Working Capital to Revenue	1,045.79%	3,429.60%	4,943.87%	0.00%	0.00%
Earnings Adjustments	-	-	-	-	-
Adjusted Basic Earnings per Share	($1.27)	($1.35)	($0.34)	($1.07)	$0.00
Adjusted Weighted Average Basic Shares Outstanding	175.04M	159.07M	152.92M	156.48M	0.00
Adjusted Diluted Earnings per Share	($1.27)	($1.38)	($0.82)	($1.07)	$0.00
Adjusted Weighted Average Diluted Shares Outstanding	175.04M	159.58M	154.15M	156.48M	0.00
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	($1.07)	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	191.27M	168.50M	157.78M	117.22M	0.00
Normalized Net Operating Profit after Tax (NOPAT)	-141	-156	-89	-49	-16
Normalized NOPAT Margin	-609.36%	-2,040.50%	-1,434.06%	0.00%	0.00%
Pre Tax Income Margin	-970.47%	-2,809.59%	-832.34%	0.00%	0.00%
Debt Service Ratios	-	-	-	-	-
EBIT to Interest Expense	-33.81	-50.35	0.00	-672.32	-369.56
NOPAT to Interest Expense	-25.03	-36.17	0.00	-260.24	-153.93
EBIT Less CapEx to Interest Expense	-45.04	-64.22	0.00	-905.39	-621.46
NOPAT Less CapEx to Interest Expense	-36.25	-50.04	0.00	-493.31	-405.83
Payout Ratios	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	-24.95%	0.00%
Augmented Payout Ratio	0.00%	-0.01%	-0.02%	-24.98%	0.00%

This table displays calculated financial ratios and metrics derived from Enovix's official financial filings.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/30/2025	12/29/2024	9/29/2024	6/30/2024	3/31/2024	12/31/2023	10/1/2023	7/2/2023	4/2/2023	1/1/2023	10/2/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-3.30%	31.65%	2,058.50%	8,871.43%	25,004.76%	575.30%	2,400.00%	-99.18%	0.00%	0.00%	0.00%
EBITDA Growth	32.29%	24.35%	6.04%	-85.41%	67.47%	-275.50%	80.12%	-15,114.56%	-268.03%	87.55%	-699.72%
EBIT Growth	49.72%	41.16%	-13.88%	-84.58%	36.18%	-350.80%	77.37%	-3,652.04%	-278.22%	83.44%	-676.55%
NOPAT Growth	39.32%	46.72%	2.22%	-71.18%	-10.89%	-43.46%	-49.60%	-84.96%	-76.29%	-82.35%	-75.45%
Net Income Growth	49.39%	37.62%	-39.87%	-80.31%	36.83%	-436.96%	80.27%	-5,565.73%	-272.34%	86.78%	-656.72%
EPS Growth	57.14%	90.48%	-3.45%	-63.41%	40.43%	-520.00%	45.28%	-127.78%	-193.75%	108.20%	-278.57%
Operating Cash Flow Growth	51.75%	41.39%	-8.63%	-14.42%	-36.83%	-24.69%	-37.09%	-14.27%	-30.08%	-30.04%	-6.36%
Free Cash Flow Firm Growth	70.38%	64.09%	-83.13%	-5,664.75%	-256.14%	-13.44%	-54.95%	109.49%	-143.90%	0.00%	-3,087.98%
Invested Capital Growth	15.50%	20.50%	210.33%	2,018.12%	697.79%	285.11%	419.79%	-88.99%	42.59%	156.74%	161.68%
Revenue Q/Q Growth	-47.54%	125.09%	14.57%	-28.53%	-28.57%	3,590.50%	376.19%	100.00%	-98.08%	13,562.50%	-99.84%
EBITDA Q/Q Growth	46.11%	-96.38%	87.02%	-392.98%	40.66%	-143.93%	74.39%	13.50%	-594.90%	87.09%	-19,502.91%
EBIT Q/Q Growth	34.32%	-72.19%	82.33%	-151.63%	23.14%	-233.28%	71.36%	12.99%	-442.85%	83.27%	-4,648.24%
NOPAT Q/Q Growth	-23.31%	29.94%	44.49%	-26.54%	-8.27%	-28.57%	2.82%	18.03%	-40.08%	-34.07%	-20.15%
Net Income Q/Q Growth	37.17%	-65.44%	80.48%	-149.36%	22.55%	-270.95%	74.83%	12.63%	-558.29%	86.37%	-7,125.82%
EPS Q/Q Growth	-500.00%	93.33%	55.22%	-139.29%	-33.33%	27.59%	29.27%	12.77%	-1,040.00%	109.43%	-194.44%
Operating Cash Flow Q/Q Growth	-5.95%	47.99%	-13.85%	23.10%	-28.71%	3.60%	-19.93%	8.04%	-17.28%	-5.98%	0.03%
Free Cash Flow Firm Q/Q Growth	-3.62%	62.72%	15.01%	9.77%	-25.62%	-90.10%	-2,682.50%	105.77%	59.99%	-159.67%	-58.19%
Invested Capital Q/Q Growth	8.58%	4.13%	45.80%	-29.94%	13.28%	168.18%	895.17%	-73.61%	-45.32%	261.97%	-78.92%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	5.12%	10.83%	-14.87%	-17.38%	-34.14%	-167.84%	-8,304.50%	-33,792.86%	-58,223.81%	-847.48%	-82,762.50%
EBITDA Margin	-313.12%	-304.87%	-349.43%	-3,084.53%	-447.19%	-530.57%	-8,027.00%	-149,247.62%	-345,100.00%	-954.16%	-1,009,550.00%
Operating Margin	-834.84%	-355.21%	-1,141.23%	-2,355.36%	-1,330.35%	-877.62%	-25,191.50%	-123,440.48%	-301,190.48%	-4,131.20%	-420,987.50%
EBIT Margin	-478.83%	-382.50%	-500.00%	-3,242.25%	-920.90%	-855.85%	-9,477.00%	-157,585.71%	-362,233.33%	-1,282.07%	-1,046,987.50%
Profit (Net Income) Margin	-461.57%	-385.43%	-524.39%	-3,077.15%	-881.96%	-813.41%	-8,092.50%	-153,109.52%	-350,490.48%	-1,022.96%	-1,025,162.50%
Tax Burden Percent	99.32%	103.17%	110.73%	96.20%	99.67%	98.96%	100.00%	100.00%	100.00%	100.00%	100.00%
Interest Burden Percent	97.06%	97.66%	94.71%	98.66%	96.08%	96.04%	85.39%	97.16%	96.76%	79.79%	97.92%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	-84.79%	-40.25%	-167.47%	-509.99%	-145.70%	-57.66%	-831.83%	-4,117.46%	-84,006.65%	0.00%	0.00%
ROIC Less NNEP Spread (ROIC-NNEP)	-92.91%	-28.45%	-178.01%	-475.59%	-147.07%	-51.20%	-838.73%	-4,108.53%	-83,998.29%	0.00%	0.00%
Return on Net Nonoperating Assets (RNNOA)	30.50%	12.56%	94.70%	354.00%	102.53%	37.69%	759.78%	3,811.61%	80,419.60%	0.00%	0.00%
Return on Equity (ROE)	-54.30%	-27.68%	-72.78%	-156.00%	-43.18%	-19.97%	-72.05%	-305.85%	-3,587.05%	-15.13%	-36.66%
Cash Return on Invested Capital (CROIC)	-109.78%	-137.75%	-295.65%	-538.97%	-356.86%	-315.45%	-648.38%	-395.39%	-797.57%	-551.40%	0.00%
Operating Return on Assets (OROA)	-21.76%	-16.17%	-21.42%	-104.85%	-25.83%	-13.02%	-26.03%	-357.49%	-4,916.98%	-17.23%	-12,115.92%
Return on Assets (ROA)	-20.97%	-16.30%	-22.47%	-99.51%	-24.74%	-12.37%	-22.22%	-347.34%	-4,757.58%	-13.75%	-11,863.36%
Return on Common Equity (ROCE)	-53.66%	-27.38%	-72.32%	-154.97%	-42.95%	-19.87%	-72.05%	-305.85%	-3,587.05%	-15.13%	-36.66%
Return on Equity Simple (ROE_SIMPLE)	-84.87%	0.00%	-146.26%	-140.14%	-81.57%	0.00%	-65.46%	-93.46%	-53.81%	0.00%	-34.89%
Net Operating Profit after Tax (NOPAT)	-30	-24	-34	-62	-49	-45	-35	-36	-44	-32	-24
NOPAT Margin	-584.39%	-248.65%	-798.86%	-1,648.75%	-931.24%	-614.33%	-17,634.05%	-86,408.33%	-210,833.33%	-2,891.84%	-294,691.25%
Net Nonoperating Expense Percent (NNEP)	8.12%	-11.79%	10.54%	-34.40%	1.37%	-6.46%	6.90%	-8.93%	-8.36%	5.77%	-16.99%
Return On Investment Capital (ROIC_SIMPLE)	-7.14%	-5.64%	-	-	-	-10.40%	-	-	-	-8.87%	-
Cost of Revenue to Revenue	94.88%	89.17%	114.87%	117.38%	134.14%	267.84%	8,404.50%	33,892.86%	58,323.81%	947.48%	82,862.50%
SG&A Expenses to Revenue	331.35%	135.18%	480.52%	554.25%	370.79%	241.25%	8,622.50%	39,733.33%	129,876.19%	1,411.25%	163,875.00%
R&D to Revenue	508.61%	230.86%	561.04%	771.36%	925.42%	468.53%	6,754.00%	39,411.90%	113,090.48%	1,422.23%	174,350.00%
Operating Expenses to Revenue	839.96%	366.04%	1,126.36%	2,337.98%	1,296.21%	709.78%	16,887.00%	89,647.62%	242,966.67%	3,283.71%	338,225.00%
Earnings before Interest and Taxes (EBIT)	-24	-37	-22	-122	-49	-63	-19	-66	-76	-14	-84
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-16	-30	-15	-116	-24	-39	-16	-63	-72	-10	-81
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	6.08	8.14	10.04	15.43	5.89	8.14	7.96	11.54	7.54	5.48	8.04
Price to Tangible Book Value (P/TBV)	7.62	10.13	14.28	22.03	7.62	10.30	7.96	11.54	7.54	5.48	8.04
Price to Revenue (P/Rev)	62.48	87.01	81.14	158.13	104.67	274.79	1,482.00	2,451.21	378.03	315.12	563.97
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	8.07	12.30	11.13	24.95	8.65	15.25	37.44	538.86	112.13	48.59	273.00
Enterprise Value to Revenue (EV/Rev)	59.60	83.07	80.27	154.05	98.25	257.94	1,331.37	2,242.93	330.83	263.06	495.66
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.76	0.72	1.06	1.04	0.76	0.67	0.66	0.67	0.00	0.00	0.00
Long-Term Debt to Equity	0.71	0.68	0.99	0.97	0.73	0.65	0.66	0.67	0.00	0.00	0.00
Financial Leverage	-0.33	-0.44	-0.53	-0.74	-0.70	-0.74	-0.91	-0.93	-0.96	-1.04	-1.01
Leverage Ratio	2.15	2.14	2.29	2.45	1.69	1.63	1.62	1.52	1.25	1.35	1.29
Compound Leverage Factor	2.08	2.09	2.17	2.41	1.62	1.56	1.38	1.47	1.21	1.08	1.27
Debt to Total Capital	43.02%	41.82%	51.43%	50.91%	43.23%	40.13%	39.82%	40.28%	0.00%	0.00%	0.00%
Short-Term Debt to Total Capital	2.48%	2.20%	3.30%	3.12%	2.08%	1.36%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	40.54%	39.62%	48.14%	47.79%	41.16%	38.77%	39.82%	40.28%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.63%	0.62%	0.76%	0.78%	0.69%	0.68%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	56.34%	57.56%	47.81%	48.31%	56.08%	59.19%	60.18%	59.72%	100.00%	100.00%	100.00%
Debt to EBITDA	-1.02	-0.97	-0.93	-0.92	-1.25	-0.92	-1.03	-0.74	0.00	0.00	0.00
Net Debt to EBITDA	0.39	0.51	0.11	0.36	0.61	0.69	1.26	1.07	0.00	0.00	0.00
Long-Term Debt to EBITDA	-0.96	-0.92	-0.87	-0.86	-1.19	-0.89	-1.03	-0.74	0.00	0.00	0.00
Debt to NOPAT	-1.19	-1.06	-0.94	-0.94	-1.06	-1.09	-1.13	-1.23	0.00	0.00	0.00
Net Debt to NOPAT	0.46	0.55	0.11	0.37	0.52	0.82	1.39	1.79	0.00	0.00	0.00
Long-Term Debt to NOPAT	-1.12	-1.00	-0.88	-0.88	-1.01	-1.05	-1.13	-1.23	0.00	0.00	0.00
Altman Z-Score	1.31	2.52	1.51	2.52	1.38	2.87	3.70	4.95	12.98	13.46	14.99
Noncontrolling Interest Sharing Ratio	1.16%	1.10%	0.63%	0.65%	0.52%	0.48%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	4.68	5.49	3.77	3.98	4.89	5.30	8.52	11.07	12.00	14.31	20.28
Quick Ratio	4.37	5.17	3.41	3.71	4.65	5.07	8.42	10.95	11.70	14.03	19.91
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-52	-51	-136	-160	-177	-141	-74	2.87	-50	-124	-48
Operating Cash Flow to CapEx	-269.56%	-97.55%	-157.08%	-106.90%	-232.26%	-94.49%	-163.69%	-185.57%	-844.69%	-450.62%	-121.97%
Free Cash Flow to Firm to Interest Expense	-30.59	-29.47	-79.10	-94.56	-106.82	-86.60	-47.66	2.26	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	-9.85	-9.28	-17.86	-15.94	-21.12	-16.71	-18.14	-18.54	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	-13.51	-18.80	-29.23	-30.84	-30.22	-34.40	-29.22	-28.54	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.05	0.04	0.04	0.03	0.03	0.02	0.00	0.00	0.01	0.01	0.01
Accounts Receivable Turnover	9.90	8.43	21.69	19.47	14.75	14.17	387.43	16.17	0.00	0.00	0.00
Inventory Turnover	2.69	3.06	7.41	9.33	15.75	13.46	160.86	59.34	0.00	0.00	0.00
Fixed Asset Turnover	0.14	0.14	0.14	0.12	0.10	0.06	0.01	0.01	0.07	0.07	0.06
Accounts Payable Turnover	1.15	1.63	2.17	2.93	4.82	4.45	4.28	4.46	11.13	4.55	3.43
Days Sales Outstanding (DSO)	36.86	43.30	16.83	18.74	24.75	25.76	0.94	22.58	0.00	0.00	0.00
Days Inventory Outstanding (DIO)	135.73	119.16	49.27	39.12	23.18	27.12	2.27	6.15	0.00	0.00	0.00
Days Payable Outstanding (DPO)	318.10	223.36	167.86	124.41	75.76	81.98	85.34	81.76	32.80	80.27	106.36
Cash Conversion Cycle (CCC)	-145.51	-60.90	-101.77	-66.55	-27.83	-29.10	-82.13	-53.03	-32.80	-80.27	-106.36
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	169	156	150	103	146	129	48	4.85	18	34	9.28
Invested Capital Turnover	0.15	0.16	0.21	0.31	0.16	0.09	0.05	0.05	0.40	-0.48	-1.77
Increase / (Decrease) in Invested Capital	23	27	101	98	128	96	39	-39	5.48	93	24
Enterprise Value (EV)	1,365	1,917	1,665	2,561	1,267	1,972	1,805	2,611	2,059	1,632	2,532
Market Capitalization	1,431	2,008	1,683	2,628	1,350	2,101	2,010	2,853	2,353	1,954	2,881
Book Value per Share	$1.23	$1.39	$0.95	$1.00	$1.36	$1.54	$1.58	$1.56	$1.98	$2.27	$2.28
Tangible Book Value per Share	$0.98	$1.11	$0.67	$0.70	$1.05	$1.22	$1.58	$1.56	$1.98	$2.27	$2.28
Total Capital	417	429	351	353	409	436	420	414	312	356	358
Total Debt	180	179	180	179	177	175	167	167	0.00	0.00	0.00
Total Long-Term Debt	169	170	169	169	168	169	167	167	0.00	0.00	0.00
Net Debt	-69	-94	-21	-70	-86	-132	-204	-242	-294	-323	-349
Capital Expenditures (CapEx)	6.27	16	20	25	15	29	17	13	3.03	4.85	17
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-25	-22	-25	-37	-33	-39	-40	-33	-18	-16	-11
Debt-free Net Working Capital (DFNWC)	223	251	176	213	230	268	332	376	276	307	338
Net Working Capital (NWC)	212	241	165	202	221	262	332	376	276	307	338
Net Nonoperating Expense (NNE)	-6.26	13	-12	54	-2.60	15	-19	28	29	-20	58
Net Nonoperating Obligations (NNO)	-69	-94	-21	-70	-86	-132	-204	-242	-294	-323	-349
Total Depreciation and Amortization (D&A)	8.45	7.54	6.50	5.94	25	24	2.90	3.50	3.60	3.58	3.00
Debt-free, Cash-free Net Working Capital to Revenue	-110.94%	-95.83%	-119.74%	-221.97%	-254.21%	-506.79%	-2,929.79%	-2,818.99%	-282.97%	-261.72%	-215.80%
Debt-free Net Working Capital to Revenue	972.71%	1,086.75%	849.07%	1,281.72%	1,780.63%	3,507.01%	24,455.09%	32,339.43%	4,437.44%	4,943.87%	6,615.42%
Net Working Capital to Revenue	927.44%	1,045.79%	793.35%	1,215.61%	1,714.80%	3,429.60%	24,455.09%	32,339.43%	4,437.44%	4,943.87%	6,615.42%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.12)	($0.19)	($0.13)	($0.67)	($0.28)	($0.37)	($0.10)	($0.41)	($0.47)	($0.08)	($0.53)
Adjusted Weighted Average Basic Shares Outstanding	191.30M	175.04M	176.68M	172.40M	168.14M	159.07M	159.83M	157.15M	155.63M	152.92M	153.33M
Adjusted Diluted Earnings per Share	($0.12)	($0.02)	($0.30)	($0.67)	($0.28)	($0.21)	($0.29)	($0.41)	($0.47)	$0.05	($0.53)
Adjusted Weighted Average Diluted Shares Outstanding	191.30M	175.04M	176.87M	172.40M	168.14M	159.58M	161.37M	157.15M	155.63M	154.15M	153.33M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	192.00M	191.27M	177.98M	176.28M	170.00M	168.50M	167.77M	320.25M	316.32M	157.78M	157.10M
Normalized Net Operating Profit after Tax (NOPAT)	-30	-24	-32	-35	-49	-45	-33	-33	-44	-32	-24
Normalized NOPAT Margin	-584.39%	-248.65%	-739.50%	-940.10%	-931.24%	-614.33%	-16,576.70%	-79,056.67%	-210,833.33%	-2,891.84%	-294,691.25%
Pre Tax Income Margin	-464.75%	-373.57%	-473.57%	-3,198.86%	-884.84%	-821.99%	-8,092.50%	-153,109.52%	-350,490.48%	-1,022.96%	-1,025,162.50%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-14.23	-21.62	-12.56	-72.25	-29.26	-38.78	-12.17	-52.12	0.00	0.00	0.00
NOPAT to Interest Expense	-17.36	-14.06	-20.07	-36.74	-29.59	-27.84	-22.65	-28.58	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	-17.88	-31.14	-23.93	-87.15	-38.36	-56.47	-23.26	-62.11	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	-21.02	-23.57	-31.44	-51.65	-38.69	-45.52	-33.73	-38.57	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.02%	-0.02%

Frequently Asked Questions About Enovix's Financials

When does Enovix's fiscal year end?

According to the most recent income statement we have on file, Enovix's financial year ends in December. Their financial year 2024 ended on December 29, 2024.

How has Enovix's net income changed over the last 4 years?

Enovix's net income appears to be on an upward trend, with a most recent value of -$222.53 million in 2024, rising from -$39.65 million in 2020. The previous period was -$214.13 million in 2023. View Enovix's forecast to see where analysts expect Enovix to go next.

What is Enovix's operating income?

Enovix's total operating income in 2024 was -$242.67 million, based on the following breakdown:

Total Gross Profit: -$2.05 million
Total Operating Expenses: $240.62 million

How has Enovix revenue changed over the last 4 years?

Over the last 4 years, Enovix's total revenue changed from $0.00 in 2020 to $23.07 million in 2024, a change of 2,307,400,000.0%.

How much debt does Enovix have?

Enovix's total liabilities were at $277.77 million at the end of 2024, a 8.4% decrease from 2023, and a 866.2% increase since 2020.

How much cash does Enovix have?

In the past 4 years, Enovix's cash and equivalents has ranged from $29.14 million in 2020 to $385.29 million in 2021, and is currently $272.87 million as of their latest financial filing in 2024.

How has Enovix's book value per share changed over the last 4 years?

Over the last 4 years, Enovix's book value per share changed from 0.45 in 2020 to 1.39 in 2024, a change of 207.7%.

Related Companies

This page (NASDAQ:ENVX) was last updated on 5/29/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Enovix (ENVX) Financials

Frequently Asked Questions About Enovix's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Enovix (ENVX) Financials

Annual Income Statements for Enovix

Quarterly Income Statements for Enovix

Annual Cash Flow Statements for Enovix

Quarterly Cash Flow Statements for Enovix

Annual Balance Sheets for Enovix

Quarterly Balance Sheets for Enovix

Annual Metrics And Ratios for Enovix

Quarterly Metrics And Ratios for Enovix

Frequently Asked Questions About Enovix's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools